arrow
返回
I

Ian Chau

Royal Marsden NHS Foundation Trust

81H指数
848论文数
4.5W被引数
收录论文 265
发表时间
Total Neoadjuvant Approach for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma—UK Tertiary Cancer Centre Experience对于 borderline 可切除和局部晚期胰腺腺癌的术前新辅助治疗——英国三级癌症中心的经验
errCancers
IF4.4
err2026-05-16
err0
errOAAI
errKai Tai Derek Yeung; Simon Gomberg; William Hodgson; Petula Jefferies; David Cunningham; Sheela Rao; Ian Chau; Naureen Starling; Charlotte Fribbens; Avani Athauda; Diana Tait; Irene Chong; Arabella Hunt; Magnus T. Dillon; Sacheen Kumar; Long R. Jiao; Ricky H. Bhogal; Katharine Aitken
err分享
err收藏
Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial晚期食管胃腺癌一线铂类化疗后卡培他滨维持治疗:PLATFORM试验的最终分析
err2026-04-21
err0
errOAAI
errAnderley Gordon; Amina Tran; Caroline Fong; Susan Cromarty; Katarzyna Piadel; Oleg Zhitkov; Becky Leamon; Catherine Cafferkey; Michael Davidson; Prantik Das; Russell Petty; Tom Roques; Madeleine Hewish; Carys Morgan; Tom Waddell; Suzanne Darby; Alexander Bradshaw; Sheela Rao; Naureen Starling; Ian Chau; David Cunningham
err分享
err收藏
err分享
err收藏
The role of PET/CT in peripheral T-cell lymphoma: Results from the PET/CT substudy of the UK NCRI phase 2 CHEMO-T trialPET/CT在外周T细胞淋巴瘤中的作用:来自英国NCRI第2阶段CHEMO-T试验PET/CT亚组研究的结果
err2025-05-26
err0
PREAI
errM. Gleeson; C. Gonzalez Arias; D. Cunningham; C. Peckitt; K. Thomas; Y. Du; N. Hujairi; Y. M. To; H. C. Chen; S. Patel; I. Chau; P. Johnson; A. Wotherspoon; A. D. Attygalle; E. A. Hawkes; M. P. Macheta; G. P. Collins; K. Cwynarski; S. Chua
err分享
err收藏
Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypND and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study术前化疗后复发风险高的胃和食管胃交界癌患者的辅助免疫治疗 (ypND和/或R1): 欧洲癌症研究与治疗组织 (EORTC) 1707痕迹研究
err2025-02-01
err3
errOAAI
errLordick, F.; Mauer, M. E.; Stocker, G.; Cella, C. A.; Ben-Aharon, I.; Piessen, G.; Wyrwicz, L.; Al-Haidari, G.; Fleitas-Kanonnikoff, T.; Boige, V.; Obermannova, R. Lordick; Martens, U. M.; Gomez-Martin, C.; Thuss-Patience, P.; Arrazubi, V.; Avallone, A.; Shiu, K. K.; Artru, P.; Brenner, B.; Sanchez, C. Buges; Chau, I.; Lorenzen, S.; Daum, S.; Sinn, M.; Merelli, B.; van Grieken, N. C. T.; Nilsson, M.; Collienne, M.; Giraut, A.; Smyth, E.
err分享
err收藏
HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01HER2-related生物标志物可预测曲妥珠单抗deruxtecan治疗HER2-expressing转移性结直肠癌患者的临床结局: DESTINY-CRC01的生物标志物分析
err2024-11-25
err0
errOAAI
errSiena, Salvatore; Raghav, Kanwal; Masuishi, Toshiki; Yamaguchi, Kensei; Nishina, Tomohiro; Elez, Elena; Rodriguez, Javier; Chau, Ian; Di Bartolomeo, Maria; Kawakami, Hisato; Suto, Fumitaka; Koga, Makito; Inaki, Koichiro; Kuwahara, Yusuke; Takehara, Issey; Barrios, Daniel; Kobayashi, Kojiro; Grothey, Axel; Yoshino, Takayuki
err分享
err收藏
CNS lymphoma imaging and molecular biomarkers study: CLIMBCNS淋巴瘤影像学及分子生物标志物研究:CLIMB
err2024-09-01
err0
PREAI
errNtellas, P.; Li, S.; Hobbis, L.; Piadel, K.; Cunningham, D.; Macklin-Doherty, A.; El-Sharkawi, D.; Iyengar, S.; Nicholson, E.; Arias, C.; Easdale, S.; Chau, I.
err分享
err收藏
Maintenance capecitabine plus ramucirumab after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma (OGA): Final analysis from the PLATFORM trial在晚期食道胃腺癌(OGA)中,在一线铂类为基础的化疗后进行卡培他滨联合雷莫芦单抗的维持治疗:PLATFORM试验的最终分析
err2024-09-01
err1
PREAI
errGordon, A.; Rajan, Z.; Fong, C. Y. K.; Peckitt, C.; Satchwell, L.; Cromarty, S.; Kidd, S.; Piadel, K.; Leamon, B.; Zhitkov, O.; Davidson, M.; Thompson, J.; Maisey, N. R.; Darby, S.; Waddell, T. S.; Morgan, C.; Bradshaw, A.; Starling, N.; Chau, I.; Cunningham, D.
err分享
err收藏
Maintenance durvalumab after fi rst-line chemotherapy in patients with HER2-negative advanced oesophago-gastric adenocarcinoma: results from the randomised PLATFORM study
err2024-07-01
err0
errOAAI
errFong, C.; Patel, B.; Peckitt, C.; Bourmpaki, E.; Satchwell, L.; Cromarty, S.; Kidd, S.; von Loga, K.; Uhlik, M.; Begum, R.; Rana, T.; Waddell, T.; Darby, S.; Bradshaw, A.; Roques, T.; Morgan, C.; Rees, C.; Herbertson, R.; Das, P.; Thompson, C.; Hewish, M.; Petty, R.; Thistlethwaite, F.; Rao, S.; Starling, N.; Chau, I.; Cunningham, D.
err分享
err收藏
Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study来自UK TRACC B部分研究的结合基因组和甲基化信号的无组织液体活检,用于早期结直肠癌患者的最小残留疾病检测
err2024-06-12
err2
errOAAI
errSlater, Susanna; Bryant, Annette; Aresu, Maria; Begum, Ruwaida; Chen, Hsiang-Chi; Peckitt, Clare; Lazaro-Alcausi, Retchel; Carter, Paul; Anandappa, Gayathri; Khakoo, Shelize; Melcher, Lucinda; Potter, Vanessa; Marti, Francisca M.; Huang, Joesph; Branagan, Graham; George, Nicol; Abulafi, Muti; Duff, Sarah; Raja, Ashraf; Gupta, Ashish; West, Nicholas; Bucheit, Leslie; Rich, Thereasa; Chau, Ian; Cunningham, David; Starling, Naureen
err分享
err收藏
Phase II results of the porcupine (PORCN) inhibitor zamaporvint (RXC004) in genetically selected microsatellite stable colorectal cancer patients
err2024-06-01
err0
PREAI
errCook, N.; Bridgewater, J. A.; Saunders, M. P.; Kopetz, S.; Garcia-Carbonero, R.; Beom, S-H.; O'Neil, B. H.; Wilson, R. H.; Graham, J.; Maurel, J.; Kim, T. W.; Chau, I.; Saleha, S.; Goodwin, L.; Wilson, D.; Robertson, J.; Timmis, H.; Asken, E.; Woodcock, S. A.; Morris, V.
err分享
err收藏
Immunological markers of pathological and clinical and outcomes in mismatch repair deficient (MMRd) colorectal cancer (CRC)
err2024-06-01
err0
PREAI
errChalloner, B. R.; Slater, S. C.; Sansano, H. B.; Aresu, M.; Bryant, A.; Chen, H-C.; Begum, R.; Rana, T.; Zhitkov, O.; Leamon, B.; Barber, L. J.; Peckitt, C.; Chau, I.; Starling, N.; Cunningham, D.; Gerlinger, M.
err分享
err收藏